Breaking News
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
Understanding AFib: Why do I have this? Should I take blood thinners?

Understanding AFib: Why do I have this? Should I take blood thinners?

image_pdfDownload PDFimage_print

In my clinical practice, I’ve found that patients with the irregular heart rhythm atrial fibrillation (AFib) do the best when they contribute to their own care by:

  • Learning the difference between AFib and a normal heart rhythm.
  • Eating a heart-healthy diet that slows down underlying problems linked to AFib.
  • Gaining knowledge about AFib medications and taking them consistently.

Oftentimes, patients wonder why them — why is their heart not working as it should?

About 9 percent of people over 65 have atrial fibrillation. Although diseased arteries in the heart often lead to AFib, other causes include high blood pressure, obesity, and excessive alcohol use. It is also more common in those of European descent.

AFib comes in several forms; often it is permanent with no possibility of a return to a normal rhythm. Other times, it can come and go (a condition called paroxysmal AFib, the type that George H., who we met in our last blog post, has).

As I mentioned  there, preventing a stroke in AFib patients is a major consideration.

Unfortunately, people with this heart condition are 4 to 5 times more likely to have a stroke. AFib’s irregular heartbeat may lead to small blood clots that form within the heart. When these blood clots travel to the brain, they can produce major damage by blocking essential blood flow and causing a stroke. While AFib is a serious health condition, the good news is that the use of blood thinners drastically reduces the chance of having a stroke.

All medications have risks. While reducing the blood’s ability to clot makes blood thinners incredibly useful drugs, they also have significant risks. They must be taken carefully and only with a doctor’s advice. The most common side effect of blood-thinning medications is unwanted minor bleeding or bruising. Serious bleeding, while less common, is most likely to occur in the digestive tract, particularly in the lining of the stomach.

Since there are inherent risks in taking blood thinners, deciding who is a good candidate to use them is always a balancing act.

It is critical to carefully weigh the prevention of a future stroke against the potential for increased bleeding. Doctors frequently use a stroke risk scoring system called CHADS2-VASc to help with the decision about who should take blood thinners. The guidelines for the scoring system follow a couple basic rules:  Blood thinners are recommended if any ONE of these risk factors is present:

  • Age 75 years or older,
  • A past stroke or mini-stroke, or
  • A past blood clot.

Blood thinners are also favored if any TWO of these risk factors are present:

  • Female
  • Age 65-74 years,
  • Heart failure,
  • High blood pressure,
  • Diabetes, or
  • Vascular disease (e.g., chest pain, carotid artery disease, heart attack).

The more risk factors you have, the greater the chance of having a stroke and the more reason to use blood thinners to protect against a stroke. For those with none of these risk factors, the possibility of harm from these drugs is greater than the possible benefits. In general, the risk of having a stroke is the same whether AFib is permanent or only occurs occasionally.

We introduced George H. in our last blog post. He is a 71-year-old retired engineer with episodes of AFib. Based on the risk factors for stroke reviewed above, should George take blood thinners?

Let’s check out his risk factors: He is 71 years-old and taking medications for high blood pressure, although he has none of the other listed stroke risk factors. Based on his age (1 point) and having high blood pressure (1 point), George’s risk of a stroke is 2 percent per year. Following the guidelines, the doctor started him on a blood thinner. But as we’ll see, George came to have some second thoughts about this, his blood thinners were more than he bargained for.

Knowing your stroke risk score is a critical piece of information for every patient with AFib. Several online tools are available to help calculate stroke risk scores. You can use this easy-to-use, online risk scoring calculator to help assess your situation and then work with your doctor to review your personal calculations.

This is the second in a series of blog posts called Understanding AFib to help patients with atrial fibrillation live healthier lives. The first blog post explained AFib, while the next blog post will review blood thinning drugs. George H. is an actual patient with some details altered to protect his confidentiality.

Randall Stafford, MD, PhD, is a professor of medicine at Stanford and practices primary care internal medicine. Stafford and Stanford cardiologist Paul Wang, MD, lead an American Heart Association effort to improve stroke prevention decision-making in atrial fibrillation.

Photo by rawpixel

Tagged with:

About author

Related Articles